Hiroyuki Takata

Oita, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Unrelated hematopoietic stem cell transplantation with post-transplant cyclophosphamide for myelodysplastic syndrome with anti-HLA antibodies

Unrelated hematopoietic stem cell transplantation with post-transplant cyclophosphamide for myelodysplastic syndrome with anti-HLA antibodies

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 03, 2026

Real-world treatment outcomes of peripheral T-cell lymphoma in the era of molecular targeted therapy.

Real-world treatment outcomes of peripheral T-cell lymphoma in the era of molecular targeted therapy.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: June 28, 2026

CD19-negative relapse with an apparent cytogenetic shift after blinatumomab-induced measurable residual disease clearance in Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.

CD19-negative relapse with an apparent cytogenetic shift after blinatumomab-induced measurable residual disease clearance in Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.

Journal: Leukemia research reports

Published: May 18, 2026

Allogeneic hematopoietic stem cell transplantation with high-dose melphalan and total body irradiation for hematological malignancies: a single-center retrospective analysis

Allogeneic hematopoietic stem cell transplantation with high-dose melphalan and total body irradiation for hematological malignancies: a single-center retrospective analysis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: December 07, 2025

Outcome of allogeneic hematopoietic stem cell transplantation for myelofibrosis

Outcome of allogeneic hematopoietic stem cell transplantation for myelofibrosis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: March 05, 2025

HLA-haploidentical allogeneic hematopoietic stem cell transplantation using FluMelTBI conditioning for an elderly patient with fulminant aplastic anemia during treatment for chronic lymphocytic leukemia

HLA-haploidentical allogeneic hematopoietic stem cell transplantation using FluMelTBI conditioning for an elderly patient with fulminant aplastic anemia during treatment for chronic lymphocytic leukemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: January 08, 2025

Philadelphia Chromosome as a Clinically Favorable Prognostic Factor of B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Transplant-Ineligible Elderly Patients in the Era of Molecular-Targeted Therapy.

Philadelphia Chromosome as a Clinically Favorable Prognostic Factor of B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Transplant-Ineligible Elderly Patients in the Era of Molecular-Targeted Therapy.

Journal: Cureus

Published: November 19, 2024

Pyogenic spondylitis after Corynebacterium striatum blood stream infection following allogeneic hematopoietic stem cell transplantation for malignant lymphoma

Pyogenic spondylitis after Corynebacterium striatum blood stream infection following allogeneic hematopoietic stem cell transplantation for malignant lymphoma

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: April 29, 2024

Plasmablastic lymphoma presenting with plasmacytosis and polyclonal hypergammopathy

Plasmablastic lymphoma presenting with plasmacytosis and polyclonal hypergammopathy

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: March 06, 2024

Multiple myeloma with myelofibrosis at diagnosis and aggressive extramedullary relapse after autologous stem cell transplantation

Multiple myeloma with myelofibrosis at diagnosis and aggressive extramedullary relapse after autologous stem cell transplantation

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: February 04, 2024

Treatment outcomes of mantle cell lymphoma in real-world practice: analysis of forty-one patients.

Treatment outcomes of mantle cell lymphoma in real-world practice: analysis of forty-one patients.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: September 28, 2023

Poor clinical outcome of relapsed/refractory diffuse large B-cell lymphoma with MYC translocation treated with polatuzumab vedotin, bendamustine, and rituximab.

Poor clinical outcome of relapsed/refractory diffuse large B-cell lymphoma with MYC translocation treated with polatuzumab vedotin, bendamustine, and rituximab.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: July 30, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026